Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
There is uncertainty about the site(s) of action of the antidiabetic thiazolidinediones (TZDs). These drugs are agonist ligands of the transcription factor PPARγ, which is abundant in adipose tissue but is normally present at very low levels in liver and muscle. We have studied the effects of TZDs i...
Збережено в:
| Опубліковано в:: | J Clin Invest |
|---|---|
| Автори: | , , , , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
American Society for Clinical Investigation
2000
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC381440/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11086023/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI11245 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|